Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication used to treat and reduce the risk of blood clots. From Wikipedia
The move follows a restructuring that refocuses spending on deals to strengthen CSL’s bleeding-disorder portfolio.
